WallStSmart

Diversified Healthcare Trust (DHC)vsVentas Inc (VTR)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Ventas Inc generates 278% more annual revenue ($5.82B vs $1.54B). VTR leads profitability with a 4.3% profit margin vs -18.6%. VTR appears more attractively valued with a PEG of 1.74. VTR earns a higher WallStSmart Score of 55/100 (C).

DHC

Hold

42

out of 100

Grade: D

Growth: 4.0Profit: 2.0Value: 6.7Quality: 7.0
Piotroski: 4/9Altman Z: -0.02

VTR

Buy

55

out of 100

Grade: C

Growth: 7.3Profit: 5.0Value: 4.7Quality: 3.8
Piotroski: 4/9Altman Z: 0.39
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for DHC.

VTRSignificantly Overvalued (-591.0%)

Margin of Safety

-591.0%

Fair Value

$12.40

Current Price

$82.70

$70.30 premium

UndervaluedFair: $12.40Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

DHC1 strengths · Avg: 10.0/10
Price/BookValuation
1.0x10/10

Reasonable price relative to book value

VTR2 strengths · Avg: 8.0/10
Operating MarginProfitability
20.3%8/10

Strong operational efficiency at 20.3%

Revenue GrowthGrowth
21.4%8/10

Revenue surging 21.4% year-over-year

Areas to Watch

DHC4 concerns · Avg: 3.5/10
PEG RatioValuation
1.894/10

Expensive relative to growth rate

Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

Market CapQuality
$1.62B3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.613/10

Elevated debt levels

VTR4 concerns · Avg: 3.0/10
PEG RatioValuation
1.744/10

Expensive relative to growth rate

Return on EquityProfitability
2.2%3/10

ROE of 2.2% — below average capital efficiency

Profit MarginProfitability
4.3%3/10

4.3% margin — thin

P/E RatioValuation
153.2x2/10

Premium valuation, high expectations priced in

Comparative Analysis Report

WallStSmart Research

Bull Case : DHC

The strongest argument for DHC centers on Price/Book.

Bull Case : VTR

The strongest argument for VTR centers on Operating Margin, Revenue Growth. Revenue growth of 21.4% demonstrates continued momentum.

Bear Case : DHC

The primary concerns for DHC are PEG Ratio, Revenue Growth, Market Cap. Debt-to-equity of 1.61 is elevated, increasing financial risk.

Bear Case : VTR

The primary concerns for VTR are PEG Ratio, Return on Equity, Profit Margin. A P/E of 153.2x leaves little room for execution misses. Thin 4.3% margins leave little buffer for downturns.

Key Dynamics to Monitor

DHC profiles as a turnaround stock while VTR is a growth play — different risk/reward profiles.

DHC carries more volatility with a beta of 2.39 — expect wider price swings.

VTR is growing revenue faster at 21.4% — sustainability is the question.

VTR generates stronger free cash flow (368M), providing more financial flexibility.

Bottom Line

VTR scores higher overall (55/100 vs 42/100) and 21.4% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Diversified Healthcare Trust

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

DHC is a real estate investment trust, or REIT, that owns medical offices and life science properties, senior communities and wellness centers throughout the United States. The company is headquartered in Newton, MA.

Visit Website →

Ventas Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Ventas, Inc. is a real estate investment trust specializing in the ownership and management of health care facilities in the United States, Canada and the United Kingdom.

Want to dig deeper into these stocks?